Dr. Pamela Ann Hays, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 230 E Marydale Ave, Suite 2, Soldotna, AK 99669 Phone: 907-260-3691 |
Dr. Steven A Stephens, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 230 East Marydale Ave, Soldotna, AK 99669 Phone: 907-260-3691 Fax: 907-260-7301 |
Dr. Kristie Kay Sellers, PHD Psychologist - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 245 N Binkley St Ste 202, Soldotna, AK 99669 Phone: 907-714-4521 |
Dr. Peter Paul Cannava, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 230 E Marydale Ave, Suite 1, Soldotna, AK 99669 Phone: 907-260-3691 Fax: 907-260-7301 |
Dr. Kathleen L Dinius, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 174 E Redoubt Ave, Soldotna, AK 99669 Phone: 907-262-1260 Fax: 907-262-4403 |
Dr. Matthew Meador Dammeyer, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 250 Hospital Pl, Soldotna, AK 99669 Phone: 907-714-4520 |
News Archive
Arteriocyte, Inc., a leading clinical stage biotechnology company with offices in Cleveland, Ohio, and Hopkinton, Massachusetts, that develops proprietary stem cell and tissue engineering based therapies announced today the launch of its first commercially available Stem Cell Expansion System for research use.
Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin will develop the process to manufacture a unique therapeutic monoclonal antibody conjugate for diagnostic imaging purposes.
SunLink Health Systems, Inc. today announced earnings from continuing operations for its fiscal quarter ended March 31, 2011 of $2,515,000, or $0.31 per fully diluted share, compared to earnings from continuing operations of $469,000, or $0.06 per fully diluted share, for the comparable quarter ended March 31, 2010.
Factors such as maternal high blood pressure and high hematocrit levels (the proportion of blood that consists of red blood cells) are associated with a greater likelihood of restricted fetal growth during the first trimester, with restricted growth linked to an increased risk of preterm birth and low birth weight, according to a study in the February 10 issue of JAMA.
› Verified 7 days ago